TearScience’s Boorady Touts LipiFlow’s Duration
Joseph Boorady, president and CEO, TearScience, shares details on recent studies that demonstrated LipiFlow’s ability to deliver long-term relief for dry eye sufferers. He also reveals some exciting early commercial success.
Participant:
Joseph Boorady
Joe Boorady serves as President and CEO of TearScience and has spent over 20 years in the ophthalmic industry as an executive.